Navilas® at Euretina 2019: Navigated retinal laser therapy - a unique and effective treatment platform (FOTO)

Teltow, Germany, USA (ots) -

At the EURETINA Congress in Paris, specialists report on clinical
experiences with a unique computer-assisted treatment of the retina
for fast panretinal photocoagulation and easy to control subthreshold
laser therapy

TClinical experiences with a unique and effective digital
treatment platform for the retina are presented this week to a
professional audience at the EURETINA Congress in Paris. Navigated,
retinal laser therapy with the Navilas® 577s allows for panretinal
photocoagulation with uniform spot distribution which is faster and
less painful for patients than PRP treatment with conventional
slit-lamp lasers1,2. While tissue-friendly subthreshold treatments
with navigated laser are easy to control thanks to a unique confluent
delivery method and digital documentation.

Users report on clinical outcomes of treatment with the Navilas®
577s laser in the EURETINA Satellite Meeting on Friday, September 6,
2019 at 9:45 am in room 251
(https://navilas-euretina2019.eventbrite.de/?aff=pr). Hands-on
experience with the platform can be gained at OD-OS booth no. 210.

Clinical studies show that the unique retina navigation platform
makes treatments precise, effective and comfortable.(3)

Prof. Albert Augustin, Städtisches Klinikum Karlsruhe: "Our
experience in everyday clinical practice shows that the treatment
with Navilas® is much faster and, based on this, reduces the number
of laser sessions, so that we can cope better with the steadily
growing number of patients. Our patients report less pain than with
conventional lasers."

"As therapists, we value, among other things, the targeted spot
planning with defined spacing. This increases safety during focal
treatments and supports secure closure of foramina even in the far
periphery."

Dr. Winfried Teiwes, Managing Director of OD-OS GmbH: "The
all-digital Navilas® 577s is the next generation platform after
conventional slit-lamp lasers. Navilas® brings the degree of digital
control, comfort and transparency to retinal laser treatment that
doctors are already used to from front-of-the-eye treatments. Thanks
to Navilas® unique imaging, tracking and navigation, doctors now can
focus on the medical aspects of treating the retina with confidence."

To learn more about the all-digital workflow of Navilas® 577s and
the capability to easily generate digital reports watch this video:
https://www.od-os.com/navilas-laser-systemr/multimodal-reports/

(1) https://www.ncbi.nlm.nih.gov/pubmed/24787564
(2) https://www.ncbi.nlm.nih.gov/pubmed/26840160
(3) www.od-os.com/publications

About OD-OS: OD-OS GmbH is a privately-held medical device company
founded in 2008 with offices in Teltow, Germany, and Irvine, CA.
https://www.od-os.com

For further information, please contact:
Stefanie Gehrke, Director Marketing | stefanie.gehrke@od-os.com, +49
(172) 3808 537 OD-OS GmbH | Warthestr. 21 | 14513 Teltow | Germany

Original-Content von: OD-OS GmbH, übermittelt durch news aktuell